1. Home
  2. PWUP vs CNTB Comparison

PWUP vs CNTB Comparison

Compare PWUP & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PWUP
  • CNTB
  • Stock Information
  • Founded
  • PWUP 2021
  • CNTB 2012
  • Country
  • PWUP United States
  • CNTB China
  • Employees
  • PWUP N/A
  • CNTB N/A
  • Industry
  • PWUP Blank Checks
  • CNTB Biotechnology: Pharmaceutical Preparations
  • Sector
  • PWUP Finance
  • CNTB Health Care
  • Exchange
  • PWUP Nasdaq
  • CNTB Nasdaq
  • Market Cap
  • PWUP 87.4M
  • CNTB 82.1M
  • IPO Year
  • PWUP 2022
  • CNTB 2021
  • Fundamental
  • Price
  • PWUP $11.25
  • CNTB $1.27
  • Analyst Decision
  • PWUP
  • CNTB Strong Buy
  • Analyst Count
  • PWUP 0
  • CNTB 2
  • Target Price
  • PWUP N/A
  • CNTB $6.50
  • AVG Volume (30 Days)
  • PWUP 237.0
  • CNTB 93.1K
  • Earning Date
  • PWUP 01-01-0001
  • CNTB 04-16-2024
  • Dividend Yield
  • PWUP N/A
  • CNTB N/A
  • EPS Growth
  • PWUP N/A
  • CNTB N/A
  • EPS
  • PWUP 0.18
  • CNTB N/A
  • Revenue
  • PWUP N/A
  • CNTB N/A
  • Revenue This Year
  • PWUP N/A
  • CNTB N/A
  • Revenue Next Year
  • PWUP N/A
  • CNTB N/A
  • P/E Ratio
  • PWUP $62.50
  • CNTB N/A
  • Revenue Growth
  • PWUP N/A
  • CNTB N/A
  • 52 Week Low
  • PWUP $10.07
  • CNTB $0.54
  • 52 Week High
  • PWUP $13.70
  • CNTB $2.84
  • Technical
  • Relative Strength Index (RSI)
  • PWUP 44.86
  • CNTB 39.56
  • Support Level
  • PWUP $11.26
  • CNTB $1.22
  • Resistance Level
  • PWUP $11.69
  • CNTB $1.41
  • Average True Range (ATR)
  • PWUP 0.00
  • CNTB 0.14
  • MACD
  • PWUP -0.00
  • CNTB -0.01
  • Stochastic Oscillator
  • PWUP 9.52
  • CNTB 10.68

About PWUP PowerUp Acquisition Corp.

PowerUp Acquisition Corp is a blank check company. It is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Share on Social Networks: